missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Honokiol, 98+%, Thermo Scientific™
Induces apoptosis in human squamous lung cancer cells
Marke: Thermo Scientific Alfa Aesar J63434.MA
| Menge | 10mg |
|---|
Dieser Artikel kann nicht zurückgegeben werden.
Rückgaberichtlinie anzeigen
Beschreibung
This Thermo Scientific brand product was originally part of the Alfa Aesar product portfolio. Some documentation and label information may refer to the legacy brand. The original Alfa Aesar product / item code or SKU reference has not changed as a part of the brand transition to Thermo Scientific.
Chemische Identifikatoren
| 35354-74-6 | |
| 266.34 | |
| FVYXIJYOAGAUQK-UHFFFAOYSA-N | |
| 72303 | |
| 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol |
| C18H18O2 | |
| MFCD00016674 | |
| honokiol, 5,3'-diallyl-2,4'-dihydroxybiphenyl, 3,5'-diallyl-4,2'-dihydroxybiphenyl, unii-11513cco0n, chembl16901, 3',5-diallyl-1,1'-biphenyl-2,4'-diol, 4-allyl-2-3-allyl-4-hydroxy-phenyl phenol, 3',5-diallyl-2,4'-biphenyldiol, 3',5-diallylbiphenyl-2,4'-diol, 5,3′-diallyl-2,4′-dihydroxydiphenyl | |
| CHEBI:5759 | |
| C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C |
Spezifikation
| Honokiol | |
| C18H18O2 | |
| 10mg | |
| 14,4742 | |
| FVYXIJYOAGAUQK-UHFFFAOYSA-N | |
| 2-(4-hydroxy-3-prop-2-enylphenyl)-4-prop-2-enylphenol | |
| 72303 | |
| 266.34 |
| 35354-74-6 | |
| MFCD00016674 | |
| UN3077 | |
| honokiol, 5,3'-diallyl-2,4'-dihydroxybiphenyl, 3,5'-diallyl-4,2'-dihydroxybiphenyl, unii-11513cco0n, chembl16901, 3',5-diallyl-1,1'-biphenyl-2,4'-diol, 4-allyl-2-3-allyl-4-hydroxy-phenyl phenol, 3',5-diallyl-2,4'-biphenyldiol, 3',5-diallylbiphenyl-2,4'-diol, 5,3′-diallyl-2,4′-dihydroxydiphenyl | |
| C=CCC1=CC(=C(C=C1)O)C2=CC(=C(C=C2)O)CC=C | |
| 266.34 | |
| CHEBI:5759 | |
| ≥98% |
Name des Produkts
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.
Spot an opportunity for improvement?